These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 103434)

  • 1. Savings achieved through use of a less concentrated amino acid solution.
    Ivey MF; Baluch W; Mueller W
    Am J Hosp Pharm; 1979 Jan; 36(1):57-9. PubMed ID: 103434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions.
    Pearson VE; King LM
    Hosp Pharm; 1992 Jul; 27(7):610, 613-4. PubMed ID: 10119189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fiscal impact of a total nutrient admixture program at a pediatric hospital.
    Eskew JA
    Am J Hosp Pharm; 1987 Jan; 44(1):111-4. PubMed ID: 3103430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of amino acids and the availability of acid in total parenteral nutrition solutions containing hydrochloric acid.
    Mirtallo JM; Rogers KR; Johnson JA; Fabri PJ; Schneider PJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1729-31. PubMed ID: 6795923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titratable acidities of crystalline amino acid admixtures.
    Sturgeon RJ; Athanikar NK; Henry RS; Jurgens RW; Welco AD
    Am J Hosp Pharm; 1980 Mar; 37(3):388-90. PubMed ID: 6768289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More efficient system for preparing total parenteral nutrient solutions.
    Condella F; Baptista RJ; Griffin RE
    Am J Hosp Pharm; 1983 Dec; 40(12):2146-9. PubMed ID: 6419587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a crystalline amino acid mixture for parenteral nutrition in low-birth-weight infants.
    Meng HC; Stahlman MT; Otten A; Dolanski EA; Caldwell MD; O'Neill JA
    Pediatrics; 1977 May; 59(5):699-709. PubMed ID: 404620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of an enteral products formulary.
    Durfee DD; Skinner-Domet VM
    Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four-hour single-container system for parenteral nutrient admixtures.
    Raebel MA; McDonald JB
    Am J Hosp Pharm; 1985 Jun; 42(6):1355-8. PubMed ID: 3925769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
    Oh T; Franko TG
    Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist monitoring of parenteral nutrition: clinical and cost effectiveness.
    Mutchie KD; Smith KA; MacKay MW; Marsh C; Juluson D
    Am J Hosp Pharm; 1979 Jun; 36(6):785-7. PubMed ID: 111548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a 2-liter plastic container for parenteral nutrient solutions.
    Thorn DB; Tanner DJ
    Am J Hosp Pharm; 1984 Apr; 41(4):680-5. PubMed ID: 6426298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid stability and microbial growth in total parenteral nutrient solutions.
    Parr MD; Bertch KE; Rapp RP
    Am J Hosp Pharm; 1985 Dec; 42(12):2688-91. PubMed ID: 3936355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.